Veradermics, Incorporated (MANE) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -4481.1%, revenue growth 4597.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.56M |
| Revenue (TTM) | $0.0B |
| Net Margin | -4481.1% |
| Operating Margin (TTM) | -1238.8% |
| Revenue Growth (YoY) | 4597.1% |
| EPS Growth (YoY) | -97.6% |
| FCF Growth (YoY) | 23.1% |
| Price / Book | 5.06 |
| Price / Sales | 520.77 |
| FCF Yield | -1.7% |
| Altman Z-Score | 6.43 (safe) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
MANE overview · MANE earnings · MANE KPIs · MANE documents · MANE ownership · MANE peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.